Cyclopamine,HedgehogAntagonist M60022-2s|产品详情|进口橙子视频旧款采购网

您好，欢迎来到橙子视频app安卓下载生物网站！请登录注册

我的订单 | 联系橙子视频app安卓下载 | 在线客服QQ：3012681483 | 客服电话：400-968-7988 | 工作时间：08:30-17:30

主营产品： ELISA91橙子视频、抗体、补体血清、兔补体、干扰素、小鼠测温仪、进口橙子视频旧款、Quidel代理、Swant代理、PBL Assay Science代理

网站首页产品中心代理品牌新闻资讯资源中心关于橙子视频app安卓下载

所在位置：首页 > 产品中心 > Xcessbio > Xcessbio产品

订购信息

上海橙子视频app安卓下载生物科技公司

Tel:400-968-7988 021-33779008

Cyclopamine,HedgehogAntagonist

品牌：Xcessbio

货号：M60022-2s

规格：2 mg solid

货期：

应用：

咨询客服

立即购买加入购物车

Cyclopamine,HedgehogAntagonist

商品详情参考文献相关资料

Product Information

Chemical Name:	(2'R,3S,3'R,3a'S,6aS,6bS,6'S,7a'R,11aS,11bR)-3',6',10,11b-tetramethyl-1,2,3,3a',4,4',5',6,6a,6b,6',7,7',7a',8,11,11a,11b-octadecahydro-3'H-spiro[benzo[a]fluorene-9,2'-furo[3,2-b]pyridin]-3-ol
Molecular Weight:	411.62
Formula:	C₂₇H₄₁NO
Purity:	≥98%
CAS#:	4449-51-8
Solubility:	DMSO up to 20 mM
Storage:	Powder: 4^oC 1 year DMSO: 4^oC 3 month -20^oC 1 year

Biological Activity:

Cyclopamine is a potent and selective inhibitor of the hedgehog signaling with an IC₅₀ ~46 nM, acting as an antagonist of Smoothened. It is a natural product isolated from the corn lily (Veratrum californicum). As the hedgehog signaling pathway plays very important roles in embryogenesis and cancer progression, Cyclopamine has been used in stem cell differentiation, such as pancreatic cell differentiation from ESC/iPSC, or treating Hh pathway dependent cancer in vitro and in vivo.

How to Use:

In vitro: Cyclopamine was used at 3 µM in vitro and in cellular assays.
In vivo: Cycloppamine was administered at 50 mg/kg by subcutaneous injection once per day in tumor xenograft mouse model.

Reference:

1. Chen JK, et al. Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. (2002) Genes Dev. 16(21):2743-8.
2. Scott MP. Cancer: a twist in a hedgehog's tale. (2003) Nature. 425(6960):780-2.
3. D'Amour KA, et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. (2006) Nat Biotechnol. 24(11):1392-401.
4. Bar EE, et al. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. (2007) Stem Cells. 25(10):2524-33.
5. Jiang J, et al. Hedgehog signaling in development and cancer. (2008) Dev Cell. 15(6):801-12.